Molecular Imaging of Neurodegeneration

神经退行性变的分子成像

• 批准号: nhmrc : 1046471
• 负责人: A/Pr Victor Villemagne
• 金额: $ 55.35万
• 依托单位: The University of Melbourne
• 依托单位国家: 澳大利亚
• 项目类别: Research Fellowships
• 财政年份: 2013
• 资助国家: 澳大利亚
• 起止时间: 2013-01-01 至 2018-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/molecular-imaging-neurodegeneration/111844
• 关键词: Molecular; Imaging; Neurodegeneration

This research proposal outlines studies aimed at identifying specific biomarkers of neurodegeneration. Given the complexity and clinical overlap of these disorders the identification of diagnostic biomarkers for their early detection is crucial; especially in the identification of at-risk individuals before the development of symptoms. This will allow early intervention with disease-modifying medications which by arresting neuronal loss would prevent or delay onset of the disease.

这项研究计划概述了旨在确定神经退行性变的特定生物标志物的研究。考虑到这些疾病的复杂性和临床重叠性，鉴定用于其早期检测的诊断生物标志物是至关重要的;特别是在症状发展之前鉴定处于风险中的个体。这将允许早期干预与疾病修饰药物，通过阻止神经元的损失将防止或延迟疾病的发作。